We recently cloned the murine homologue of Cyp26B1, a novel retinoic acid (RA)-metabolizing enzyme and showed that its gene expression pattern is unique from that of Cyp26A1 during early embryogenesis. Here, we complete this comparative expression analysis from embryonic day (E) 12 to postnatal stages. Cyp26B1 expression was found in developing tendons and precartilaginous elements and in perichondrium by E14.5, while Cyp26A1 expression was restricted to extremities of rib and vertebral cartilage. Cyp26A1 and Cyp26B1 were expressed, in the distal epithelium and mesenchyme of the limbs and genital tubercle, respectively. High Cyp26B1 expression was found in craniofacial areas undergoing morphogenetic growth, whereas Cyp26A1 message was restricted to the mouth and dental epithelium. Cyp26A1 alone was expressed in the developing neural retina, while both genes were co-expressed in the retinal pigment epithelium. Cyp26B1 was specifically expressed in the developing hindbrain (pons, cerebellum) and forebrain (striatum, hippocampus), with forebrain expression persisting postnatally. In addition, Cyp26B1 was expressed at specific levels of the differentiating upper and lower thoracic spinal cord, adjacent to the cervical and lumbar regions that express the RA-synthesizing enzyme RALDH-2. In viscera, Cyp26B1 transcripts were detected in the developing lung, kidney, spleen, thymus and testis, whereas Cyp26A1 transcripts were found in the diaphragm and outer stomach mesenchyme. Cyp26B1 was also specifically expressed in dermis surrounding the developing hair follicles. Regulated RA metabolism may therefore be required in many developing systems. q
Retinoic acid (RA), the most biologically active metabolite of vitamin A (retinol), is an indispensable hormonal signal during vertebrate development (Niederreither et al., 1999 ; for a review, see Ross et al., 2000) . Reports on the expression and function of RA-synthesizing (RALDH1, 2 and 3) (Niederreither et al., 1997; Haselbeck et al., 1999; Li et al., 2000; Mic et al., 2000) and metabolizing (CYP26A1 and CYP26B1) (White et al., 1996; Fujii et al., 1997; White et al., 1997; Abu-Abed et al., 1998; White et al., 2000; MacLean et al., 2001 ) enzymes have shed new light on how RA distribution in developing tissues is finely controlled. Embryonic regions expressing Raldh2 have been shown to be rich in RA and are bounded by regions expressing Cyp26A1, which are devoid of RA; examples of this complementarity have been described during formation of the antero-posterior axis (Swindell et al., 1999) and in the developing tailbud region (Sakai et al., 2001) , as well as in the embryonic retina (McCaffery et al., 1999) . Disruption of either the RA-synthesizing or RA-degrading pathways results in embryonic lethality as observed in knockouts of the Raldh2 (Niederreither et al., 1999) and Cyp26A1 (Abu- Sakai et al., 2001 ) genes. Cyp26A1 null mutant embryos Sakai et al., 2001) exhibit defects similar to those observed following RA teratogenicity in utero, particularly in the developing tailbud (Alles and Sulik, 1990; Shum et al., 1999) . Thus, the highly regulated Raldh and Cyp26 gene expression patterns may define an uneven RA distribution that governs the progression of normal embryonic development in most tissues.
Recently, we described a novel human (White et al., Mechanisms of Development 110 (2002) 2000) and murine CYP26 family member, CYP26B1 and showed that its gene expression is both spatially and temporally distinct from that of Cyp26A1 during early embryogenesis (MacLean et al., 2001) . To further our understanding of the role of these enzymes, we have extended their comparative expression analyses to later stages of development.
Results

Expression in the developing skeleton, tendons, limbs and genital tubercle
In situ hybridization of 35 S-labelled Cyp26A1 and Cyp26B1 riboprobes on histological sections showed unique gene expression patterns at E12.5 and E14.5 (Fig. 1A-F) . At E12.5, Cyp26B1 expression was detected in the prevertebral column (Fig. 1C) , the rib anlagen (data not shown) and the limb precartilaginous blastemas (Fig. 2C) . The level of expression decreased as the prevertebrae underwent cartilaginous differentiation by E14.5 (see the caudal to cranial gradient of expression in the prevertebrae Fig. 1F ) and Cyp26B1 expression eventually became restricted to the various perichondrial areas (Fig. 2I,L,O) . Cyp26B1 was expressed in extraskeletal structures, which based on their shape and location correspond to the developing tendons (Fig. 2F,I ,O). Cyp26B1 expression was undetectable in the developing muscles ( Fig. 2I and data not shown).
Cyp26A1 expression has been previously reported in some preskeletal elements (de Roos et al., 1999) . When compared to Cyp26B1, its expression was more restricted towards the extremities of the vertebral arches (not shown), ribs ( Fig. 2K ) and pelvic bone elements (Fig. 2N) . Furthermore, unlike Cyp26B1, Cyp26A1 was not detected in the proximal limb skeleton (Fig. 2H) or the midsagittal portion of the prevertebrae (Fig. 1B,E) .
In limbs, Cyp26B1 was also expressed along the anterior and posterior footplate mesenchyme and the very distal digit mesenchyme (Fig. 2C,F ). This pattern of expression is reminiscent of Cyp26B1 expression in the distal 'progress zone' mesenchyme of the limb bud at earlier developmental stages (MacLean et al., 2001) . In comparison, the expression of Cyp26A1 was observed in the periphalangeal mesenchyme and the distal limb ectoderm at E12.5, which was subsequently downregulated by E14.5 (Fig. 2B,E) . Cyp26B1 transcripts were also detected in the genital tubercle mesenchyme (Fig. 1F, inset) , whose proximo-distal outgrowth shares common properties with the limb buds (Haraguchi et al., 2000) , whereas Cyp26A1 was weakly expressed in the genital tubercle epithelium (Fig. 1E , inset).
Expression in craniofacial structures
Cyp26B1 exhibited complex expression patterns in the differentiating craniofacial mesenchyme. Moderate expression was seen in precartilaginous elements (e.g. otic capsule in Fig. 1C ; palatal shelves and mandibular bone in Fig. 3J ; laryngeal cartilage in Fig. 3F ,G). Cyp26B1 transcripts were also detected in regions that do not undergo cartilage differentiation, such as the superficial tongue mesenchyme (Fig.  3J ). Increased expression was detected toward the extremities of the nasal processes (Figs. 1C and 3J ), in the recesses separating the developing nasal turbinates (Fig. 3D,E ) at the 5 ). Abbreviations: bl, urinary bladder; di, diaphragm; fb, forebrain; gt, genital tubercle; hb, hindbrain; li, liver; md, mandibular process; np, nasal process; oc, otic capsule; oe, oesophagus; pv, prevertebrae; sc, spinal cord; tl, tail. Fig. 7) . Abbreviations: c, cartilage; dm, (limb) distal mesenchyme; ep, (limb) epithelium; h, humerus; hf, hair follicle; m, muscle; os, ossification centre; ph, phalanges; r, radius; t, tendon; u, ulna.
level of the oesophageal-laryngeal bifurcation (Fig. 3F,G) , in palpebral (Fig. 3C , arrows) and external ear (not shown) mesenchyme. Taken together, these increased Cyp26B1 patterns of expression may correlate with regions that are undergoing morphogenetic changes.
Cyp26A1 expression was restricted to the mouth and tongue epithelium (Fig. 3I) , the dental laminae (Fig. 3I) and by E18.5, to the dental epithelium, including the enamel organ (Fig. 3L) . Cyp26A1 also exhibited a restricted expression in the medial portion of the developing neural retina and the surrounding prospective pigment epithelium; Cyp26B1 was only expressed in the prospective retinal pigment epithelium (compare Fig 3B,C) .
Cyp26B1 expression in foetal and adult brain
At E12.5 and E14.5, Cyp26B1 transcripts were observed in a defined hindbrain domain that encompassed the entire pons and cerebellum (Figs. 1C and 4A,B) . The anterior expression boundary was at the level of the met-mesencephalic isthmus, although transcripts extended dorsally along the tectum (midbrain). Expression was strongest in the inner ventricular cell layer. Cyp26B1 was also expressed in the differentiating hippocampal field at E14.5 (Fig. 4B) . Cyp26B1 transcripts appeared in striatal cells between E14.5 and E16.5 (Figs. 3C and 4C,D) ; these forebrain expression sites persisted postnatally. Thus, Cyp26B1 was expressed in the CA3 region of the adult brain hippocampus, subiculum and amygdaloid nuclei (Fig. 4E-H) . Cyp26B1 signal was also detected in the inner meningeal layer (Fig.  4G,H) . No specific Cyp26A1 signal was detected in foetal or postnatal brain (data not shown).
Cyp26B1 expression in the developing spinal cord
Cyp26B1 was expressed in specific regions of the developing spinal cord (Fig. 1C,F) . Its transcript distribution was compared to that of Raldh2, which is specifically expressed in the lateral motor columns at the brachial and lumbar levels that innervate the forelimb and hindlimb, respectively (Sockanathan and Jessell, 1998) (Fig. 5A) . Cyp26B1-positive cells were found in the upper and lower thoracic regions (Fig. 5B ) which, respectively, abut the Raldh2 brachial (Fig.  5C ,D) and lumbar ( Fig. 5F ) transcript domains. Thus, a large thoracic portion of the spinal cord expressed . Abbreviations: an, amygdaloid nuclei; CA1, CA3, hippocampal areas; ce, cerebellum; cx, cerebral cortex; dg, dentate gyrus; fb, forebrain; hb, hindbrain; hi, hippocampus (or hippocampal differentiating field); ht, hypothalamus; ie, inner ear; is, isthmus; mb, midbrain; nc, nasal cavities; pa, pallidum; pi, pituitary; pm, pia-mater; po, pons; st, striatum; su, subiculum; te, tectum; th, thalamus. Abbreviations: am, ameloblasts; dl, dental lamina; fb, forebrain; hf, hair follicle; lc, laryngeal cartilage; le, lens; mc, mouth cavity; md, mandible; mx, maxillary; na, nasopharynx; np, nasal process; ns, nasal septum; od, odontoblasts; oe, oesophagus; ol, olfactory epithelium; or, oropharynx; pa, palpebral fissure; ps, palatal shelf; re, retina; st, striatum; to, tongue.
Cyp26B1 only (Fig. 5E) . Furthermore, Cyp26B1-expressing cells were distributed towards more medial regions of the spinal cord (Fig. 5D-F) . Thus, the presence of CYP26B1 may be required to restrict RALDH2-mediated RA signaling to discrete regions of the spinal cord.
Expression in the developing visceral organs
Cyp26A1 transcripts were detected in the outer mesenchyme of the oesophagus and stomach left wall, as well as in the septum transversum (developing diaphragm) at E12.5 (Fig. 1B) . By E14.5, Cyp26A1 signal was restricted to the developing atrioventricular valve (Fig. 6B) , whereas Cyp26B1 transcripts were found in endocardial cells of the outflow tract region of the heart (Fig. 6C) . No Cyp26A1 signal was detected in the developing lungs ( Fig. 6E and data not shown) . However, Cyp26B1 showed low levels of expression in the lung parenchyma at E16.5 and E18.5 (Fig. 5F and data not shown) . Neither of the Cyp26 transcripts was detected in the liver (Figs. 1E, F and 6H, I) and only Cyp26B1 was expressed in the developing spleen (Fig. 6I ) and thymus at E14.5 (data not shown). Cyp26B1 exhibited a punctuate expression pattern in the differentiating kidney (Fig. 6L) , which suggests that its expression may be induced at a specific stage of nephron differentiation. Cyp26A1 signal was weaker and only evident in a few cells of the kidney (Fig. 6K) . Only Cyp26B1 transcripts were detected in the foetal testis, particularly in cells located outside of the developing testicular cords (data not shown). 
Cyp26B1 expression in differentiating skin
Cyp26B1 was specifically expressed at the level of the developing hair follicles by E14.5 (Figs. 2I and 3C) , with transcripts being restricted to dermal cells surrounding the hair epithelium (Fig. 7A,B) . More widespread Cyp26B1 expression was seen in the E18.5 dermis (Fig. 7C,D) . No Cyp26A1 signal was detected in the developing skin (data not shown).
Materials and methods
In situ hybridization was performed with 35 S-labelled riboprobes on cryosections of CD1 mouse embryos or organs as described by Niederreither and Dollé (1998) . The Cyp26 template plasmids were described by MacLean et al. (2001) and the Raldh2 plasmid by Niederreither et al. (1997) .
